Nuvectis Pharma Inc (NASDAQ: NVCT) is a clinical-stage biopharmaceutical company focused on developing precision medicines for oncology indications with unmet medical need. The company generates no product revenue, as its drug candidates remain in clinical development. Incorporated in Delaware in July 2020, Nuvectis selects and advances drug candidates based on scientific data related to cancer-promoting factors, combined with its understanding of regulatory requirements for precision oncology. As a clinical-stage company, it is funded through capital raises rather than product sales. The 10-K filed February 11, 2026 (accession 0001104659-26-013044) identifies risks across financial condition, development, regulation, intellectual property, third-party reliance, and commercial activities, consistent with a pre-revenue biotech operating on a capital consumption model.

Revenue model

No product revenue as of the 10-K filed February 11, 2026. The company operates on a capital consumption model, funding operations through equity raises rather than commercial product sales.

Products and services

Clinical-stage drug candidates in precision oncology targeting serious conditions with unmet medical need. Specific product candidate names are not detailed in the provided filing excerpts.

Customers and end markets

End market is oncology, targeting serious cancer indications with unmet medical need. No commercial customers as of the filing date, as products remain in clinical development.

Value-chain role

Drug developer operating in clinical-stage research and development, reliant on third parties for aspects of development and with no manufacturing or commercial sales infrastructure disclosed.

Geographic exposure

Incorporated in Delaware. No specific geographic revenue or operational footprint disclosed in the provided filing excerpts.

Source: SEC 10-K, filed 2026-02-11

Industry: Pharmaceutical Preparations Peers: Astria Therapeutics, Inc. Candel Therapeutics Inc Greenwich Lifesciences Inc INmune Bio Inc Syros Pharmaceuticals, Inc. Olema Pharmaceuticals Inc Praxis Precision Medicines Inc Shattuck Labs Inc XBiotech Inc